Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1962 4
1963 2
1965 3
1966 3
1969 6
1970 6
1971 2
1973 4
1974 1
1975 5
1976 5
1977 4
1978 7
1979 12
1980 11
1981 18
1982 16
1983 15
1984 12
1985 20
1986 17
1987 17
1988 37
1989 53
1990 20
1991 16
1992 23
1993 23
1994 23
1995 27
1996 24
1997 30
1998 40
1999 41
2000 39
2001 67
2002 52
2003 53
2004 77
2005 69
2006 72
2007 87
2008 81
2009 66
2010 54
2011 52
2012 48
2013 30
2014 34
2015 27
2016 22
2017 20
2018 17
2019 21
2020 16
2021 17
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

1,476 results
Results by year
Filters applied: . Clear all
Page 1
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19.
Doi Y, Hibino M, Hase R, Yamamoto M, Kasamatsu Y, Hirose M, Mutoh Y, Homma Y, Terada M, Ogawa T, Kashizaki F, Yokoyama T, Koba H, Kasahara H, Yokota K, Kato H, Yoshida J, Kita T, Kato Y, Kamio T, Kodama N, Uchida Y, Ikeda N, Shinoda M, Nakagawa A, Nakatsumi H, Horiguchi T, Iwata M, Matsuyama A, Banno S, Koseki T, Teramachi M, Miyata M, Tajima S, Maeki T, Nakayama E, Taniguchi S, Lim CK, Saijo M, Imai T, Yoshida H, Kabata D, Shintani A, Yuzawa Y, Kondo M. Doi Y, et al. Among authors: kita t. Antimicrob Agents Chemother. 2020 Nov 17;64(12):e01897-20. doi: 10.1128/AAC.01897-20. Print 2020 Nov 17. Antimicrob Agents Chemother. 2020. PMID: 32958718 Free PMC article. Clinical Trial.
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators. Yokoyama M, et al. Among authors: kita t. Lancet. 2007 Mar 31;369(9567):1090-8. doi: 10.1016/S0140-6736(07)60527-3. Lancet. 2007. PMID: 17398308 Clinical Trial.
Toward the realization of a better aged society: messages from gerontology and geriatrics.
Arai H, Ouchi Y, Yokode M, Ito H, Uematsu H, Eto F, Oshima S, Ota K, Saito Y, Sasaki H, Tsubota K, Fukuyama H, Honda Y, Iguchi A, Toba K, Hosoi T, Kita T; Members of Subcommittee for Aging. Arai H, et al. Among authors: kita t. Geriatr Gerontol Int. 2012 Jan;12(1):16-22. doi: 10.1111/j.1447-0594.2011.00776.x. Geriatr Gerontol Int. 2012. PMID: 22188494 Review.
MicroRNAs and Lipoprotein Metabolism.
Horie T, Baba O, Kuwabara Y, Yokode M, Kita T, Kimura T, Ono K. Horie T, et al. Among authors: kita t. J Atheroscler Thromb. 2014;21(1):17-22. doi: 10.5551/jat.20859. Epub 2013 Nov 19. J Atheroscler Thromb. 2014. PMID: 24257466 Free article. Review.
Case of bleomycin-induced scleroderma.
Inaoki M, Kawabata C, Nishijima C, Yoshio N, Kita T. Inaoki M, et al. Among authors: kita t. J Dermatol. 2012 May;39(5):482-4. doi: 10.1111/j.1346-8138.2011.01301.x. Epub 2011 Sep 28. J Dermatol. 2012. PMID: 21955042 Review. No abstract available.
Recent Trends in Home Hemodialysis Therapy in Japan.
Masakane I, Hanafusa N, Kita T, Maeda K. Masakane I, et al. Among authors: kita t. Contrib Nephrol. 2017;189:54-60. doi: 10.1159/000450671. Epub 2016 Dec 12. Contrib Nephrol. 2017. PMID: 27951549 Review.
MicroRNA-33a/b in lipid metabolism – novel “thrifty” models.
Ono K, Horie T, Nishino T, Baba O, Kuwabara Y, Yokode M, Kita T, Kimura T. Ono K, et al. Among authors: kita t. Circ J. 2015;79(2):278-84. doi: 10.1253/circj.CJ-14-1252. Epub 2015 Jan 8. Circ J. 2015. PMID: 25744742 Free article. Review.
1,476 results